We are live on
!
Find out more
GHA
GW Henssler & Associates Portfolio holdings
AUM
$2.12B
1-Year Est. Return
20.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.83%
1 Year Est. Return
+20.77%
3 Year Est. Return
+54.76%
5 Year Est. Return
+76.98%
10 Year Est. Return
+231.36%
AUM
$1.1B
AUM Growth
+$13.3M
(+1.2%)
Cap. Flow
-$24.2M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
243
New
37
Increased
59
Reduced
88
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$11.5M |
| 2 |
Kroger
KR
|
+$11M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$9.23M |
| 4 |
AT&T
T
|
+$7.54M |
| 5 |
Intercontinental Exchange
ICE
|
+$6.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$16.6M |
| 2 |
MetLife
MET
|
+$12.3M |
| 3 |
T. Rowe Price
TROW
|
+$11M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$10.8M |
| 5 |
Blackrock
BLK
|
+$7.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.28% |
| 2 | Consumer Staples | 11.92% |
| 3 | Technology | 10.82% |
| 4 | Financials | 9.16% |
| 5 | Energy | 6.97% |
Similar funds
BCM
GS
EF
AAP
IVAV
KWA
HJGA
CF
GW Henssler & Associates's Q2 2019 Portfolio in Review
As of Q2 2019, GW Henssler & Associates held 243 positions worth $1.1B, up 1.2% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
GW Henssler & Associates's Q2 2019 filing shows 37 new, 59 increased, 88 reduced and 42 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M. The largest sale was Celgene Corp, an estimated $16.6M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Technology.
- GW Henssler & Associates's largest Q2 2019 buy was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M.
- GW Henssler & Associates added most to State Street Utilities Select Sector SPDR ETF in Q2 2019, an estimated $11.5M increase.
- GW Henssler & Associates's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $16.6M.
- GW Henssler & Associates fully exited NIC Inc in Q2 2019, selling an estimated $1.2M.
- GW Henssler & Associates's ten largest holdings make up 28% of its $1.1B portfolio in Q2 2019.
- GW Henssler & Associates opened 37 new positions and closed 42 in Q2 2019.
- GW Henssler & Associates's portfolio value rose 1.2% quarter-over-quarter to $1.1B.
Based on GW Henssler & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.